N J Peake1, H E Foster, K Khawaja, T E Cawston, A D Rowan. 1. Musculoskeletal Research Group, School of Clinical Medical Sciences, Medical School Cookson Building, University of Newcastle upon Tyne, NE2 4HH, UK.
Abstract
OBJECTIVE: To measure gelatinase activities in paired synovial fluid (SF) and serum of patients with juvenile idiopathic arthritis (JIA), and to assess how these activities relate to clinical and laboratory measures of disease activity. METHODS: A quantitative protein substrate zymography method was adapted and validated for use with serum and SF. Bands of activity were measured by densitometry and correlated with standard laboratory indicators of inflammation: erythrocyte sedimentation rate and platelet count. RESULTS: Gelatinase activity was found consistently in patients with JIA, with reproducible, quantified bands of activity corresponding to pro-matrix metalloproteinase-9 (pro-MMP-9), including the neutrophil associated lipocalin complex, and pro- and active forms of MMP-2. Both active MMP-2 and pro-MMP-9 were higher in JIA serum than in controls, though no differences were seen between patients grouped according to age, disease duration, or JIA subtype. However, SF MMP-9 correlated significantly with the laboratory indicators of inflammation, as did the relative level of active MMP-2. CONCLUSIONS: Both MMP-2 and MMP-9 gelatinolytic activities are raised during active JIA and associated with inflammatory activity regardless of age and disease duration, supporting a role for MMPs in the breakdown of joint components from early in disease. These MMPs may be specific markers of active joint destruction linked to inflammatory JIA, MMP-9 as a product of infiltrating cells, and the activation of MMP-2 produced within the joint.
OBJECTIVE: To measure gelatinase activities in paired synovial fluid (SF) and serum of patients with juvenile idiopathic arthritis (JIA), and to assess how these activities relate to clinical and laboratory measures of disease activity. METHODS: A quantitative protein substrate zymography method was adapted and validated for use with serum and SF. Bands of activity were measured by densitometry and correlated with standard laboratory indicators of inflammation: erythrocyte sedimentation rate and platelet count. RESULTS: Gelatinase activity was found consistently in patients with JIA, with reproducible, quantified bands of activity corresponding to pro-matrix metalloproteinase-9 (pro-MMP-9), including the neutrophil associated lipocalin complex, and pro- and active forms of MMP-2. Both active MMP-2 and pro-MMP-9 were higher in JIA serum than in controls, though no differences were seen between patients grouped according to age, disease duration, or JIA subtype. However, SF MMP-9 correlated significantly with the laboratory indicators of inflammation, as did the relative level of active MMP-2. CONCLUSIONS: Both MMP-2 and MMP-9 gelatinolytic activities are raised during active JIA and associated with inflammatory activity regardless of age and disease duration, supporting a role for MMPs in the breakdown of joint components from early in disease. These MMPs may be specific markers of active joint destruction linked to inflammatory JIA, MMP-9 as a product of infiltrating cells, and the activation of MMP-2 produced within the joint.
Authors: M W Olson; M M Bernardo; M Pietila; D C Gervasi; M Toth; L P Kotra; I Massova; S Mobashery; R Fridman Journal: J Biol Chem Date: 2000-01-28 Impact factor: 5.157
Authors: J P Schmitz; D D Dean; Z Schwartz; D L Cochran; G M Grant; R J Klebe; H Nakaya; B D Boyan Journal: J Cell Biochem Date: 1996-06-01 Impact factor: 4.429
Authors: V Knäuper; S M Wilhelm; P K Seperack; Y A DeClerck; K E Langley; A Osthues; H Tschesche Journal: Biochem J Date: 1993-10-15 Impact factor: 3.857
Authors: Clara Luz Sampieri; Sol de la Peña; Mariana Ochoa-Lara; Roberto Zenteno-Cuevas; Kenneth León-Córdoba Journal: World J Gastroenterol Date: 2010-03-28 Impact factor: 5.742
Authors: Adeline Koh; Andre Paes Batista da Silva; Anil K Bansal; Manju Bansal; Chunxiang Sun; Hyejin Lee; Michael Glogauer; Jaro Sodek; Ron Zohar Journal: Immunology Date: 2007-08-03 Impact factor: 7.397
Authors: Anke Tscheuschler; Philipp Meffert; Friedhelm Beyersdorf; Claudia Heilmann; Nadja Kocher; Xenia Uffelmann; Philipp Discher; Matthias Siepe; Fabian A Kari Journal: PLoS One Date: 2016-11-01 Impact factor: 3.240
Authors: Grant R Zimmermann; William Avery; Alyce L Finelli; Melissa Farwell; Christopher C Fraser; Alexis A Borisy Journal: Arthritis Res Ther Date: 2009-01-26 Impact factor: 5.156